- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €9.9b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€222.80
7D
-7.9%
1Y
77.7%
UCB
Market Cap: €47.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€249.70
7D
-9.2%
1Y
58.5%
argenx
Market Cap: €47.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€773.80
7D
-1.3%
1Y
64.3%